The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global COVID-19 Molecular Diagnostics Market Research Report 2025
Synopsis
COVID-19 has seen the molecular in vitro diagnostics (IVD) industry bring out its best efforts in terms of fast test RT-PCR tests for their systems, point of care solutions, syndromic tests, high throughput systems and surge production on badly needed kits.
The global COVID-19 Molecular Diagnostics market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for COVID-19 Molecular Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding COVID-19 Molecular Diagnostics.
Report Scope
The COVID-19 Molecular Diagnostics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global COVID-19 Molecular Diagnostics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the COVID-19 Molecular Diagnostics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Cellex
Abbott
Roche
BioMedomics
BD
Henry Schein
Safecare Bio-Tech
Thermo Fisher
Bio-rad
Agilent
Ortho Clinical Diagnostics
Zhejiang Orient Gene Biotech
Innovita Biological Technology
Guangzhou Wondfo Biotech
Guangdong Hecin-Scientific
Dynamiker Biotechnology (Tianjin)
ADVAITE
Mayo Clinic Laboratories
Chembio Diagnostics
Mount Sinai Laboratory
QIAGEN
Bioer
Biosynex
Esco
Analytik Jena
Techne
Da An Gene
BGI
Shanghai ZJ Bio-Tech
Segment by Type
High-throughput Sequencing
Nucleic Acid Detection Based on Real-time Fluorescent Quantitative PCR
Immunological Detection
Segment by Application
Hospitals
Scientific Research
Biodiagnostics
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of COVID-19 Molecular Diagnostics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
COVID-19 has seen the molecular in vitro diagnostics (IVD) industry bring out its best efforts in terms of fast test RT-PCR tests for their systems, point of care solutions, syndromic tests, high throughput systems and surge production on badly needed kits.
The global COVID-19 Molecular Diagnostics market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for COVID-19 Molecular Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding COVID-19 Molecular Diagnostics.
Report Scope
The COVID-19 Molecular Diagnostics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global COVID-19 Molecular Diagnostics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the COVID-19 Molecular Diagnostics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Cellex
Abbott
Roche
BioMedomics
BD
Henry Schein
Safecare Bio-Tech
Thermo Fisher
Bio-rad
Agilent
Ortho Clinical Diagnostics
Zhejiang Orient Gene Biotech
Innovita Biological Technology
Guangzhou Wondfo Biotech
Guangdong Hecin-Scientific
Dynamiker Biotechnology (Tianjin)
ADVAITE
Mayo Clinic Laboratories
Chembio Diagnostics
Mount Sinai Laboratory
QIAGEN
Bioer
Biosynex
Esco
Analytik Jena
Techne
Da An Gene
BGI
Shanghai ZJ Bio-Tech
Segment by Type
High-throughput Sequencing
Nucleic Acid Detection Based on Real-time Fluorescent Quantitative PCR
Immunological Detection
Segment by Application
Hospitals
Scientific Research
Biodiagnostics
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of COVID-19 Molecular Diagnostics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global COVID-19 Molecular Diagnostics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 High-throughput Sequencing
1.2.3 Nucleic Acid Detection Based on Real-time Fluorescent Quantitative PCR
1.2.4 Immunological Detection
1.3 Market by Application
1.3.1 Global COVID-19 Molecular Diagnostics Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Scientific Research
1.3.4 Biodiagnostics
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global COVID-19 Molecular Diagnostics Market Perspective (2019-2030)
2.2 COVID-19 Molecular Diagnostics Growth Trends by Region
2.2.1 Global COVID-19 Molecular Diagnostics Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 COVID-19 Molecular Diagnostics Historic Market Size by Region (2019-2024)
2.2.3 COVID-19 Molecular Diagnostics Forecasted Market Size by Region (2025-2030)
2.3 COVID-19 Molecular Diagnostics Market Dynamics
2.3.1 COVID-19 Molecular Diagnostics Industry Trends
2.3.2 COVID-19 Molecular Diagnostics Market Drivers
2.3.3 COVID-19 Molecular Diagnostics Market Challenges
2.3.4 COVID-19 Molecular Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top COVID-19 Molecular Diagnostics Players by Revenue
3.1.1 Global Top COVID-19 Molecular Diagnostics Players by Revenue (2019-2024)
3.1.2 Global COVID-19 Molecular Diagnostics Revenue Market Share by Players (2019-2024)
3.2 Global COVID-19 Molecular Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by COVID-19 Molecular Diagnostics Revenue
3.4 Global COVID-19 Molecular Diagnostics Market Concentration Ratio
3.4.1 Global COVID-19 Molecular Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by COVID-19 Molecular Diagnostics Revenue in 2023
3.5 COVID-19 Molecular Diagnostics Key Players Head office and Area Served
3.6 Key Players COVID-19 Molecular Diagnostics Product Solution and Service
3.7 Date of Enter into COVID-19 Molecular Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 COVID-19 Molecular Diagnostics Breakdown Data by Type
4.1 Global COVID-19 Molecular Diagnostics Historic Market Size by Type (2019-2024)
4.2 Global COVID-19 Molecular Diagnostics Forecasted Market Size by Type (2025-2030)
5 COVID-19 Molecular Diagnostics Breakdown Data by Application
5.1 Global COVID-19 Molecular Diagnostics Historic Market Size by Application (2019-2024)
5.2 Global COVID-19 Molecular Diagnostics Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America COVID-19 Molecular Diagnostics Market Size (2019-2030)
6.2 North America COVID-19 Molecular Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America COVID-19 Molecular Diagnostics Market Size by Country (2019-2024)
6.4 North America COVID-19 Molecular Diagnostics Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe COVID-19 Molecular Diagnostics Market Size (2019-2030)
7.2 Europe COVID-19 Molecular Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe COVID-19 Molecular Diagnostics Market Size by Country (2019-2024)
7.4 Europe COVID-19 Molecular Diagnostics Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific COVID-19 Molecular Diagnostics Market Size (2019-2030)
8.2 Asia-Pacific COVID-19 Molecular Diagnostics Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific COVID-19 Molecular Diagnostics Market Size by Region (2019-2024)
8.4 Asia-Pacific COVID-19 Molecular Diagnostics Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America COVID-19 Molecular Diagnostics Market Size (2019-2030)
9.2 Latin America COVID-19 Molecular Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America COVID-19 Molecular Diagnostics Market Size by Country (2019-2024)
9.4 Latin America COVID-19 Molecular Diagnostics Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa COVID-19 Molecular Diagnostics Market Size (2019-2030)
10.2 Middle East & Africa COVID-19 Molecular Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa COVID-19 Molecular Diagnostics Market Size by Country (2019-2024)
10.4 Middle East & Africa COVID-19 Molecular Diagnostics Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Cellex
11.1.1 Cellex Company Detail
11.1.2 Cellex Business Overview
11.1.3 Cellex COVID-19 Molecular Diagnostics Introduction
11.1.4 Cellex Revenue in COVID-19 Molecular Diagnostics Business (2019-2024)
11.1.5 Cellex Recent Development
11.2 Abbott
11.2.1 Abbott Company Detail
11.2.2 Abbott Business Overview
11.2.3 Abbott COVID-19 Molecular Diagnostics Introduction
11.2.4 Abbott Revenue in COVID-19 Molecular Diagnostics Business (2019-2024)
11.2.5 Abbott Recent Development
11.3 Roche
11.3.1 Roche Company Detail
11.3.2 Roche Business Overview
11.3.3 Roche COVID-19 Molecular Diagnostics Introduction
11.3.4 Roche Revenue in COVID-19 Molecular Diagnostics Business (2019-2024)
11.3.5 Roche Recent Development
11.4 BioMedomics
11.4.1 BioMedomics Company Detail
11.4.2 BioMedomics Business Overview
11.4.3 BioMedomics COVID-19 Molecular Diagnostics Introduction
11.4.4 BioMedomics Revenue in COVID-19 Molecular Diagnostics Business (2019-2024)
11.4.5 BioMedomics Recent Development
11.5 BD
11.5.1 BD Company Detail
11.5.2 BD Business Overview
11.5.3 BD COVID-19 Molecular Diagnostics Introduction
11.5.4 BD Revenue in COVID-19 Molecular Diagnostics Business (2019-2024)
11.5.5 BD Recent Development
11.6 Henry Schein
11.6.1 Henry Schein Company Detail
11.6.2 Henry Schein Business Overview
11.6.3 Henry Schein COVID-19 Molecular Diagnostics Introduction
11.6.4 Henry Schein Revenue in COVID-19 Molecular Diagnostics Business (2019-2024)
11.6.5 Henry Schein Recent Development
11.7 Safecare Bio-Tech
11.7.1 Safecare Bio-Tech Company Detail
11.7.2 Safecare Bio-Tech Business Overview
11.7.3 Safecare Bio-Tech COVID-19 Molecular Diagnostics Introduction
11.7.4 Safecare Bio-Tech Revenue in COVID-19 Molecular Diagnostics Business (2019-2024)
11.7.5 Safecare Bio-Tech Recent Development
11.8 Thermo Fisher
11.8.1 Thermo Fisher Company Detail
11.8.2 Thermo Fisher Business Overview
11.8.3 Thermo Fisher COVID-19 Molecular Diagnostics Introduction
11.8.4 Thermo Fisher Revenue in COVID-19 Molecular Diagnostics Business (2019-2024)
11.8.5 Thermo Fisher Recent Development
11.9 Bio-rad
11.9.1 Bio-rad Company Detail
11.9.2 Bio-rad Business Overview
11.9.3 Bio-rad COVID-19 Molecular Diagnostics Introduction
11.9.4 Bio-rad Revenue in COVID-19 Molecular Diagnostics Business (2019-2024)
11.9.5 Bio-rad Recent Development
11.10 Agilent
11.10.1 Agilent Company Detail
11.10.2 Agilent Business Overview
11.10.3 Agilent COVID-19 Molecular Diagnostics Introduction
11.10.4 Agilent Revenue in COVID-19 Molecular Diagnostics Business (2019-2024)
11.10.5 Agilent Recent Development
11.11 Ortho Clinical Diagnostics
11.11.1 Ortho Clinical Diagnostics Company Detail
11.11.2 Ortho Clinical Diagnostics Business Overview
11.11.3 Ortho Clinical Diagnostics COVID-19 Molecular Diagnostics Introduction
11.11.4 Ortho Clinical Diagnostics Revenue in COVID-19 Molecular Diagnostics Business (2019-2024)
11.11.5 Ortho Clinical Diagnostics Recent Development
11.12 Zhejiang Orient Gene Biotech
11.12.1 Zhejiang Orient Gene Biotech Company Detail
11.12.2 Zhejiang Orient Gene Biotech Business Overview
11.12.3 Zhejiang Orient Gene Biotech COVID-19 Molecular Diagnostics Introduction
11.12.4 Zhejiang Orient Gene Biotech Revenue in COVID-19 Molecular Diagnostics Business (2019-2024)
11.12.5 Zhejiang Orient Gene Biotech Recent Development
11.13 Innovita Biological Technology
11.13.1 Innovita Biological Technology Company Detail
11.13.2 Innovita Biological Technology Business Overview
11.13.3 Innovita Biological Technology COVID-19 Molecular Diagnostics Introduction
11.13.4 Innovita Biological Technology Revenue in COVID-19 Molecular Diagnostics Business (2019-2024)
11.13.5 Innovita Biological Technology Recent Development
11.14 Guangzhou Wondfo Biotech
11.14.1 Guangzhou Wondfo Biotech Company Detail
11.14.2 Guangzhou Wondfo Biotech Business Overview
11.14.3 Guangzhou Wondfo Biotech COVID-19 Molecular Diagnostics Introduction
11.14.4 Guangzhou Wondfo Biotech Revenue in COVID-19 Molecular Diagnostics Business (2019-2024)
11.14.5 Guangzhou Wondfo Biotech Recent Development
11.15 Guangdong Hecin-Scientific
11.15.1 Guangdong Hecin-Scientific Company Detail
11.15.2 Guangdong Hecin-Scientific Business Overview
11.15.3 Guangdong Hecin-Scientific COVID-19 Molecular Diagnostics Introduction
11.15.4 Guangdong Hecin-Scientific Revenue in COVID-19 Molecular Diagnostics Business (2019-2024)
11.15.5 Guangdong Hecin-Scientific Recent Development
11.16 Dynamiker Biotechnology (Tianjin)
11.16.1 Dynamiker Biotechnology (Tianjin) Company Detail
11.16.2 Dynamiker Biotechnology (Tianjin) Business Overview
11.16.3 Dynamiker Biotechnology (Tianjin) COVID-19 Molecular Diagnostics Introduction
11.16.4 Dynamiker Biotechnology (Tianjin) Revenue in COVID-19 Molecular Diagnostics Business (2019-2024)
11.16.5 Dynamiker Biotechnology (Tianjin) Recent Development
11.17 ADVAITE
11.17.1 ADVAITE Company Detail
11.17.2 ADVAITE Business Overview
11.17.3 ADVAITE COVID-19 Molecular Diagnostics Introduction
11.17.4 ADVAITE Revenue in COVID-19 Molecular Diagnostics Business (2019-2024)
11.17.5 ADVAITE Recent Development
11.18 Mayo Clinic Laboratories
11.18.1 Mayo Clinic Laboratories Company Detail
11.18.2 Mayo Clinic Laboratories Business Overview
11.18.3 Mayo Clinic Laboratories COVID-19 Molecular Diagnostics Introduction
11.18.4 Mayo Clinic Laboratories Revenue in COVID-19 Molecular Diagnostics Business (2019-2024)
11.18.5 Mayo Clinic Laboratories Recent Development
11.19 Chembio Diagnostics
11.19.1 Chembio Diagnostics Company Detail
11.19.2 Chembio Diagnostics Business Overview
11.19.3 Chembio Diagnostics COVID-19 Molecular Diagnostics Introduction
11.19.4 Chembio Diagnostics Revenue in COVID-19 Molecular Diagnostics Business (2019-2024)
11.19.5 Chembio Diagnostics Recent Development
11.20 Mount Sinai Laboratory
11.20.1 Mount Sinai Laboratory Company Detail
11.20.2 Mount Sinai Laboratory Business Overview
11.20.3 Mount Sinai Laboratory COVID-19 Molecular Diagnostics Introduction
11.20.4 Mount Sinai Laboratory Revenue in COVID-19 Molecular Diagnostics Business (2019-2024)
11.20.5 Mount Sinai Laboratory Recent Development
11.21 QIAGEN
11.21.1 QIAGEN Company Detail
11.21.2 QIAGEN Business Overview
11.21.3 QIAGEN COVID-19 Molecular Diagnostics Introduction
11.21.4 QIAGEN Revenue in COVID-19 Molecular Diagnostics Business (2019-2024)
11.21.5 QIAGEN Recent Development
11.22 Bioer
11.22.1 Bioer Company Detail
11.22.2 Bioer Business Overview
11.22.3 Bioer COVID-19 Molecular Diagnostics Introduction
11.22.4 Bioer Revenue in COVID-19 Molecular Diagnostics Business (2019-2024)
11.22.5 Bioer Recent Development
11.23 Biosynex
11.23.1 Biosynex Company Detail
11.23.2 Biosynex Business Overview
11.23.3 Biosynex COVID-19 Molecular Diagnostics Introduction
11.23.4 Biosynex Revenue in COVID-19 Molecular Diagnostics Business (2019-2024)
11.23.5 Biosynex Recent Development
11.24 Esco
11.24.1 Esco Company Detail
11.24.2 Esco Business Overview
11.24.3 Esco COVID-19 Molecular Diagnostics Introduction
11.24.4 Esco Revenue in COVID-19 Molecular Diagnostics Business (2019-2024)
11.24.5 Esco Recent Development
11.25 Analytik Jena
11.25.1 Analytik Jena Company Detail
11.25.2 Analytik Jena Business Overview
11.25.3 Analytik Jena COVID-19 Molecular Diagnostics Introduction
11.25.4 Analytik Jena Revenue in COVID-19 Molecular Diagnostics Business (2019-2024)
11.25.5 Analytik Jena Recent Development
11.26 Techne
11.26.1 Techne Company Detail
11.26.2 Techne Business Overview
11.26.3 Techne COVID-19 Molecular Diagnostics Introduction
11.26.4 Techne Revenue in COVID-19 Molecular Diagnostics Business (2019-2024)
11.26.5 Techne Recent Development
11.27 Da An Gene
11.27.1 Da An Gene Company Detail
11.27.2 Da An Gene Business Overview
11.27.3 Da An Gene COVID-19 Molecular Diagnostics Introduction
11.27.4 Da An Gene Revenue in COVID-19 Molecular Diagnostics Business (2019-2024)
11.27.5 Da An Gene Recent Development
11.28 BGI
11.28.1 BGI Company Detail
11.28.2 BGI Business Overview
11.28.3 BGI COVID-19 Molecular Diagnostics Introduction
11.28.4 BGI Revenue in COVID-19 Molecular Diagnostics Business (2019-2024)
11.28.5 BGI Recent Development
11.29 Shanghai ZJ Bio-Tech
11.29.1 Shanghai ZJ Bio-Tech Company Detail
11.29.2 Shanghai ZJ Bio-Tech Business Overview
11.29.3 Shanghai ZJ Bio-Tech COVID-19 Molecular Diagnostics Introduction
11.29.4 Shanghai ZJ Bio-Tech Revenue in COVID-19 Molecular Diagnostics Business (2019-2024)
11.29.5 Shanghai ZJ Bio-Tech Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global COVID-19 Molecular Diagnostics Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of High-throughput Sequencing
Table 3. Key Players of Nucleic Acid Detection Based on Real-time Fluorescent Quantitative PCR
Table 4. Key Players of Immunological Detection
Table 5. Global COVID-19 Molecular Diagnostics Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global COVID-19 Molecular Diagnostics Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global COVID-19 Molecular Diagnostics Market Size by Region (2019-2024) & (US$ Million)
Table 8. Global COVID-19 Molecular Diagnostics Market Share by Region (2019-2024)
Table 9. Global COVID-19 Molecular Diagnostics Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 10. Global COVID-19 Molecular Diagnostics Market Share by Region (2025-2030)
Table 11. COVID-19 Molecular Diagnostics Market Trends
Table 12. COVID-19 Molecular Diagnostics Market Drivers
Table 13. COVID-19 Molecular Diagnostics Market Challenges
Table 14. COVID-19 Molecular Diagnostics Market Restraints
Table 15. Global COVID-19 Molecular Diagnostics Revenue by Players (2019-2024) & (US$ Million)
Table 16. Global COVID-19 Molecular Diagnostics Market Share by Players (2019-2024)
Table 17. Global Top COVID-19 Molecular Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in COVID-19 Molecular Diagnostics as of 2023)
Table 18. Ranking of Global Top COVID-19 Molecular Diagnostics Companies by Revenue (US$ Million) in 2023
Table 19. Global 5 Largest Players Market Share by COVID-19 Molecular Diagnostics Revenue (CR5 and HHI) & (2019-2024)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players COVID-19 Molecular Diagnostics Product Solution and Service
Table 22. Date of Enter into COVID-19 Molecular Diagnostics Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global COVID-19 Molecular Diagnostics Market Size by Type (2019-2024) & (US$ Million)
Table 25. Global COVID-19 Molecular Diagnostics Revenue Market Share by Type (2019-2024)
Table 26. Global COVID-19 Molecular Diagnostics Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 27. Global COVID-19 Molecular Diagnostics Revenue Market Share by Type (2025-2030)
Table 28. Global COVID-19 Molecular Diagnostics Market Size by Application (2019-2024) & (US$ Million)
Table 29. Global COVID-19 Molecular Diagnostics Revenue Market Share by Application (2019-2024)
Table 30. Global COVID-19 Molecular Diagnostics Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 31. Global COVID-19 Molecular Diagnostics Revenue Market Share by Application (2025-2030)
Table 32. North America COVID-19 Molecular Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 33. North America COVID-19 Molecular Diagnostics Market Size by Country (2019-2024) & (US$ Million)
Table 34. North America COVID-19 Molecular Diagnostics Market Size by Country (2025-2030) & (US$ Million)
Table 35. Europe COVID-19 Molecular Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. Europe COVID-19 Molecular Diagnostics Market Size by Country (2019-2024) & (US$ Million)
Table 37. Europe COVID-19 Molecular Diagnostics Market Size by Country (2025-2030) & (US$ Million)
Table 38. Asia-Pacific COVID-19 Molecular Diagnostics Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 39. Asia-Pacific COVID-19 Molecular Diagnostics Market Size by Region (2019-2024) & (US$ Million)
Table 40. Asia-Pacific COVID-19 Molecular Diagnostics Market Size by Region (2025-2030) & (US$ Million)
Table 41. Latin America COVID-19 Molecular Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 42. Latin America COVID-19 Molecular Diagnostics Market Size by Country (2019-2024) & (US$ Million)
Table 43. Latin America COVID-19 Molecular Diagnostics Market Size by Country (2025-2030) & (US$ Million)
Table 44. Middle East & Africa COVID-19 Molecular Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Middle East & Africa COVID-19 Molecular Diagnostics Market Size by Country (2019-2024) & (US$ Million)
Table 46. Middle East & Africa COVID-19 Molecular Diagnostics Market Size by Country (2025-2030) & (US$ Million)
Table 47. Cellex Company Detail
Table 48. Cellex Business Overview
Table 49. Cellex COVID-19 Molecular Diagnostics Product
Table 50. Cellex Revenue in COVID-19 Molecular Diagnostics Business (2019-2024) & (US$ Million)
Table 51. Cellex Recent Development
Table 52. Abbott Company Detail
Table 53. Abbott Business Overview
Table 54. Abbott COVID-19 Molecular Diagnostics Product
Table 55. Abbott Revenue in COVID-19 Molecular Diagnostics Business (2019-2024) & (US$ Million)
Table 56. Abbott Recent Development
Table 57. Roche Company Detail
Table 58. Roche Business Overview
Table 59. Roche COVID-19 Molecular Diagnostics Product
Table 60. Roche Revenue in COVID-19 Molecular Diagnostics Business (2019-2024) & (US$ Million)
Table 61. Roche Recent Development
Table 62. BioMedomics Company Detail
Table 63. BioMedomics Business Overview
Table 64. BioMedomics COVID-19 Molecular Diagnostics Product
Table 65. BioMedomics Revenue in COVID-19 Molecular Diagnostics Business (2019-2024) & (US$ Million)
Table 66. BioMedomics Recent Development
Table 67. BD Company Detail
Table 68. BD Business Overview
Table 69. BD COVID-19 Molecular Diagnostics Product
Table 70. BD Revenue in COVID-19 Molecular Diagnostics Business (2019-2024) & (US$ Million)
Table 71. BD Recent Development
Table 72. Henry Schein Company Detail
Table 73. Henry Schein Business Overview
Table 74. Henry Schein COVID-19 Molecular Diagnostics Product
Table 75. Henry Schein Revenue in COVID-19 Molecular Diagnostics Business (2019-2024) & (US$ Million)
Table 76. Henry Schein Recent Development
Table 77. Safecare Bio-Tech Company Detail
Table 78. Safecare Bio-Tech Business Overview
Table 79. Safecare Bio-Tech COVID-19 Molecular Diagnostics Product
Table 80. Safecare Bio-Tech Revenue in COVID-19 Molecular Diagnostics Business (2019-2024) & (US$ Million)
Table 81. Safecare Bio-Tech Recent Development
Table 82. Thermo Fisher Company Detail
Table 83. Thermo Fisher Business Overview
Table 84. Thermo Fisher COVID-19 Molecular Diagnostics Product
Table 85. Thermo Fisher Revenue in COVID-19 Molecular Diagnostics Business (2019-2024) & (US$ Million)
Table 86. Thermo Fisher Recent Development
Table 87. Bio-rad Company Detail
Table 88. Bio-rad Business Overview
Table 89. Bio-rad COVID-19 Molecular Diagnostics Product
Table 90. Bio-rad Revenue in COVID-19 Molecular Diagnostics Business (2019-2024) & (US$ Million)
Table 91. Bio-rad Recent Development
Table 92. Agilent Company Detail
Table 93. Agilent Business Overview
Table 94. Agilent COVID-19 Molecular Diagnostics Product
Table 95. Agilent Revenue in COVID-19 Molecular Diagnostics Business (2019-2024) & (US$ Million)
Table 96. Agilent Recent Development
Table 97. Ortho Clinical Diagnostics Company Detail
Table 98. Ortho Clinical Diagnostics Business Overview
Table 99. Ortho Clinical Diagnostics COVID-19 Molecular Diagnostics Product
Table 100. Ortho Clinical Diagnostics Revenue in COVID-19 Molecular Diagnostics Business (2019-2024) & (US$ Million)
Table 101. Ortho Clinical Diagnostics Recent Development
Table 102. Zhejiang Orient Gene Biotech Company Detail
Table 103. Zhejiang Orient Gene Biotech Business Overview
Table 104. Zhejiang Orient Gene Biotech COVID-19 Molecular Diagnostics Product
Table 105. Zhejiang Orient Gene Biotech Revenue in COVID-19 Molecular Diagnostics Business (2019-2024) & (US$ Million)
Table 106. Zhejiang Orient Gene Biotech Recent Development
Table 107. Innovita Biological Technology Company Detail
Table 108. Innovita Biological Technology Business Overview
Table 109. Innovita Biological Technology COVID-19 Molecular Diagnostics Product
Table 110. Innovita Biological Technology Revenue in COVID-19 Molecular Diagnostics Business (2019-2024) & (US$ Million)
Table 111. Innovita Biological Technology Recent Development
Table 112. Guangzhou Wondfo Biotech Company Detail
Table 113. Guangzhou Wondfo Biotech Business Overview
Table 114. Guangzhou Wondfo Biotech COVID-19 Molecular Diagnostics Product
Table 115. Guangzhou Wondfo Biotech Revenue in COVID-19 Molecular Diagnostics Business (2019-2024) & (US$ Million)
Table 116. Guangzhou Wondfo Biotech Recent Development
Table 117. Guangdong Hecin-Scientific Company Detail
Table 118. Guangdong Hecin-Scientific Business Overview
Table 119. Guangdong Hecin-Scientific COVID-19 Molecular Diagnostics Product
Table 120. Guangdong Hecin-Scientific Revenue in COVID-19 Molecular Diagnostics Business (2019-2024) & (US$ Million)
Table 121. Guangdong Hecin-Scientific Recent Development
Table 122. Dynamiker Biotechnology (Tianjin) Company Detail
Table 123. Dynamiker Biotechnology (Tianjin) Business Overview
Table 124. Dynamiker Biotechnology (Tianjin) COVID-19 Molecular Diagnostics Product
Table 125. Dynamiker Biotechnology (Tianjin) Revenue in COVID-19 Molecular Diagnostics Business (2019-2024) & (US$ Million)
Table 126. Dynamiker Biotechnology (Tianjin) Recent Development
Table 127. ADVAITE Company Detail
Table 128. ADVAITE Business Overview
Table 129. ADVAITE COVID-19 Molecular Diagnostics Product
Table 130. ADVAITE Revenue in COVID-19 Molecular Diagnostics Business (2019-2024) & (US$ Million)
Table 131. ADVAITE Recent Development
Table 132. Mayo Clinic Laboratories Company Detail
Table 133. Mayo Clinic Laboratories Business Overview
Table 134. Mayo Clinic Laboratories COVID-19 Molecular Diagnostics Product
Table 135. Mayo Clinic Laboratories Revenue in COVID-19 Molecular Diagnostics Business (2019-2024) & (US$ Million)
Table 136. Mayo Clinic Laboratories Recent Development
Table 137. Chembio Diagnostics Company Detail
Table 138. Chembio Diagnostics Business Overview
Table 139. Chembio Diagnostics COVID-19 Molecular Diagnostics Product
Table 140. Chembio Diagnostics Revenue in COVID-19 Molecular Diagnostics Business (2019-2024) & (US$ Million)
Table 141. Chembio Diagnostics Recent Development
Table 142. Mount Sinai Laboratory Company Detail
Table 143. Mount Sinai Laboratory Business Overview
Table 144. Mount Sinai Laboratory COVID-19 Molecular Diagnostics Product
Table 145. Mount Sinai Laboratory Revenue in COVID-19 Molecular Diagnostics Business (2019-2024) & (US$ Million)
Table 146. Mount Sinai Laboratory Recent Development
Table 147. QIAGEN Company Detail
Table 148. QIAGEN Business Overview
Table 149. QIAGEN COVID-19 Molecular Diagnostics Product
Table 150. QIAGEN Revenue in COVID-19 Molecular Diagnostics Business (2019-2024) & (US$ Million)
Table 151. QIAGEN Recent Development
Table 152. Bioer Company Detail
Table 153. Bioer Business Overview
Table 154. Bioer COVID-19 Molecular Diagnostics Product
Table 155. Bioer Revenue in COVID-19 Molecular Diagnostics Business (2019-2024) & (US$ Million)
Table 156. Bioer Recent Development
Table 157. Biosynex Company Detail
Table 158. Biosynex Business Overview
Table 159. Biosynex COVID-19 Molecular Diagnostics Product
Table 160. Biosynex Revenue in COVID-19 Molecular Diagnostics Business (2019-2024) & (US$ Million)
Table 161. Biosynex Recent Development
Table 162. Esco Company Detail
Table 163. Esco Business Overview
Table 164. Esco COVID-19 Molecular Diagnostics Product
Table 165. Esco Revenue in COVID-19 Molecular Diagnostics Business (2019-2024) & (US$ Million)
Table 166. Esco Recent Development
Table 167. Analytik Jena Company Detail
Table 168. Analytik Jena Business Overview
Table 169. Analytik Jena COVID-19 Molecular Diagnostics Product
Table 170. Analytik Jena Revenue in COVID-19 Molecular Diagnostics Business (2019-2024) & (US$ Million)
Table 171. Analytik Jena Recent Development
Table 172. Techne Company Detail
Table 173. Techne Business Overview
Table 174. Techne COVID-19 Molecular Diagnostics Product
Table 175. Techne Revenue in COVID-19 Molecular Diagnostics Business (2019-2024) & (US$ Million)
Table 176. Techne Recent Development
Table 177. Da An Gene Company Detail
Table 178. Da An Gene Business Overview
Table 179. Da An Gene COVID-19 Molecular Diagnostics Product
Table 180. Da An Gene Revenue in COVID-19 Molecular Diagnostics Business (2019-2024) & (US$ Million)
Table 181. Da An Gene Recent Development
Table 182. BGI Company Detail
Table 183. BGI Business Overview
Table 184. BGI COVID-19 Molecular Diagnostics Product
Table 185. BGI Revenue in COVID-19 Molecular Diagnostics Business (2019-2024) & (US$ Million)
Table 186. BGI Recent Development
Table 187. Shanghai ZJ Bio-Tech Company Detail
Table 188. Shanghai ZJ Bio-Tech Business Overview
Table 189. Shanghai ZJ Bio-Tech COVID-19 Molecular Diagnostics Product
Table 190. Shanghai ZJ Bio-Tech Revenue in COVID-19 Molecular Diagnostics Business (2019-2024) & (US$ Million)
Table 191. Shanghai ZJ Bio-Tech Recent Development
Table 192. Research Programs/Design for This Report
Table 193. Key Data Information from Secondary Sources
Table 194. Key Data Information from Primary Sources
List of Figures
Figure 1. Global COVID-19 Molecular Diagnostics Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global COVID-19 Molecular Diagnostics Market Share by Type: 2023 VS 2030
Figure 3. High-throughput Sequencing Features
Figure 4. Nucleic Acid Detection Based on Real-time Fluorescent Quantitative PCR Features
Figure 5. Immunological Detection Features
Figure 6. Global COVID-19 Molecular Diagnostics Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global COVID-19 Molecular Diagnostics Market Share by Application: 2023 VS 2030
Figure 8. Hospitals Case Studies
Figure 9. Scientific Research Case Studies
Figure 10. Biodiagnostics Case Studies
Figure 11. COVID-19 Molecular Diagnostics Report Years Considered
Figure 12. Global COVID-19 Molecular Diagnostics Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 13. Global COVID-19 Molecular Diagnostics Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global COVID-19 Molecular Diagnostics Market Share by Region: 2023 VS 2030
Figure 15. Global COVID-19 Molecular Diagnostics Market Share by Players in 2023
Figure 16. Global Top COVID-19 Molecular Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in COVID-19 Molecular Diagnostics as of 2023)
Figure 17. The Top 10 and 5 Players Market Share by COVID-19 Molecular Diagnostics Revenue in 2023
Figure 18. North America COVID-19 Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. North America COVID-19 Molecular Diagnostics Market Share by Country (2019-2030)
Figure 20. United States COVID-19 Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Canada COVID-19 Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe COVID-19 Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe COVID-19 Molecular Diagnostics Market Share by Country (2019-2030)
Figure 24. Germany COVID-19 Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. France COVID-19 Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. U.K. COVID-19 Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Italy COVID-19 Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Russia COVID-19 Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Nordic Countries COVID-19 Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific COVID-19 Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific COVID-19 Molecular Diagnostics Market Share by Region (2019-2030)
Figure 32. China COVID-19 Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Japan COVID-19 Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. South Korea COVID-19 Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Southeast Asia COVID-19 Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. India COVID-19 Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Australia COVID-19 Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America COVID-19 Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America COVID-19 Molecular Diagnostics Market Share by Country (2019-2030)
Figure 40. Mexico COVID-19 Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Brazil COVID-19 Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa COVID-19 Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa COVID-19 Molecular Diagnostics Market Share by Country (2019-2030)
Figure 44. Turkey COVID-19 Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Saudi Arabia COVID-19 Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Cellex Revenue Growth Rate in COVID-19 Molecular Diagnostics Business (2019-2024)
Figure 47. Abbott Revenue Growth Rate in COVID-19 Molecular Diagnostics Business (2019-2024)
Figure 48. Roche Revenue Growth Rate in COVID-19 Molecular Diagnostics Business (2019-2024)
Figure 49. BioMedomics Revenue Growth Rate in COVID-19 Molecular Diagnostics Business (2019-2024)
Figure 50. BD Revenue Growth Rate in COVID-19 Molecular Diagnostics Business (2019-2024)
Figure 51. Henry Schein Revenue Growth Rate in COVID-19 Molecular Diagnostics Business (2019-2024)
Figure 52. Safecare Bio-Tech Revenue Growth Rate in COVID-19 Molecular Diagnostics Business (2019-2024)
Figure 53. Thermo Fisher Revenue Growth Rate in COVID-19 Molecular Diagnostics Business (2019-2024)
Figure 54. Bio-rad Revenue Growth Rate in COVID-19 Molecular Diagnostics Business (2019-2024)
Figure 55. Agilent Revenue Growth Rate in COVID-19 Molecular Diagnostics Business (2019-2024)
Figure 56. Ortho Clinical Diagnostics Revenue Growth Rate in COVID-19 Molecular Diagnostics Business (2019-2024)
Figure 57. Zhejiang Orient Gene Biotech Revenue Growth Rate in COVID-19 Molecular Diagnostics Business (2019-2024)
Figure 58. Innovita Biological Technology Revenue Growth Rate in COVID-19 Molecular Diagnostics Business (2019-2024)
Figure 59. Guangzhou Wondfo Biotech Revenue Growth Rate in COVID-19 Molecular Diagnostics Business (2019-2024)
Figure 60. Guangdong Hecin-Scientific Revenue Growth Rate in COVID-19 Molecular Diagnostics Business (2019-2024)
Figure 61. Dynamiker Biotechnology (Tianjin) Revenue Growth Rate in COVID-19 Molecular Diagnostics Business (2019-2024)
Figure 62. ADVAITE Revenue Growth Rate in COVID-19 Molecular Diagnostics Business (2019-2024)
Figure 63. Mayo Clinic Laboratories Revenue Growth Rate in COVID-19 Molecular Diagnostics Business (2019-2024)
Figure 64. Chembio Diagnostics Revenue Growth Rate in COVID-19 Molecular Diagnostics Business (2019-2024)
Figure 65. Mount Sinai Laboratory Revenue Growth Rate in COVID-19 Molecular Diagnostics Business (2019-2024)
Figure 66. QIAGEN Revenue Growth Rate in COVID-19 Molecular Diagnostics Business (2019-2024)
Figure 67. Bioer Revenue Growth Rate in COVID-19 Molecular Diagnostics Business (2019-2024)
Figure 68. Biosynex Revenue Growth Rate in COVID-19 Molecular Diagnostics Business (2019-2024)
Figure 69. Esco Revenue Growth Rate in COVID-19 Molecular Diagnostics Business (2019-2024)
Figure 70. Analytik Jena Revenue Growth Rate in COVID-19 Molecular Diagnostics Business (2019-2024)
Figure 71. Techne Revenue Growth Rate in COVID-19 Molecular Diagnostics Business (2019-2024)
Figure 72. Da An Gene Revenue Growth Rate in COVID-19 Molecular Diagnostics Business (2019-2024)
Figure 73. BGI Revenue Growth Rate in COVID-19 Molecular Diagnostics Business (2019-2024)
Figure 74. Shanghai ZJ Bio-Tech Revenue Growth Rate in COVID-19 Molecular Diagnostics Business (2019-2024)
Figure 75. Bottom-up and Top-down Approaches for This Report
Figure 76. Data Triangulation
Figure 77. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest IT & Electronics Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
